Previous 10 | Next 10 |
2023-11-27 12:33:49 ET More on VolitionRX VolitionRx Limited (VNRX) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on VolitionRX Historical earnings data for VolitionRX Financial information for VolitionRX For further details see...
2023-11-15 15:41:07 ET VolitionRx Limited (VNRX) Q3 2023 Earnings Conference Call November 15, 2023 8:30 AM ET Company Participants Scott Powell - Executive Vice President, Investor Relations Cameron Reynolds - President and Group Chief Executive Officer Terig Hu...
VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update PR Newswire Conference call to discuss financial and operational results scheduled for Wednesday, November 15 , at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev. , ...
2023-11-14 10:52:25 ET Major earnings expected before the bell on Wednesday include: JD.com ( JD ) Tencent Holdings ( OTCPK:TCEHY ) Target ( TGT ) XPeng ( XPEV ) ZIM Integrated Shipping Services ( ZIM ) For further details see: Notable ear...
VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update PR Newswire Conference call to take place on Wednesday November 15 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev. , Nov. 8, 2023 /PRNewswire/ -- VolitionRx...
Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage Cancer PR Newswire HENDERSON, Nev. , Oct. 23, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has unveiled what it bel...
Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock PR Newswire HENDERSON, Nev. , Oct. 19, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the publicatio...
US Ambassador Adler visits Belgian Volition PR Newswire HENDERSON, Nev. , Oct. 18, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, welcomed Ambassador Michael M. Adler , U.S. Ambassador to...
Volition Presents Three Cancer Detection Abstracts at ESMO 2023 PR Newswire HENDERSON, Nev. , Oct. 16, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is presenting three scientific abstracts a...
Volition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis PR Newswire HENDERSON, Nev. , Oct. 13, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has published a report summarisi...
News, Short Squeeze, Breakout and More Instantly...
VolitionRx Limited (NYSE American: VNRX) , a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, announced the engagement of PharmaVentures Ltd (“PharmaVentures”) to act as an advisor. PharmaVentures w...
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing PR Newswire HENDERSON, Nev. , July 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed PharmaV...
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...